Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Obbina Abani(Unknown), Ahmed Abu-Arafeh, Mai Abedalla, Mahmoud Abouibrahim, Sadia Abbasi, Ahmed Abou-Haggar, Abeer Ul Amna Abeer Ul Amna, Kasim Abbas, Althaf Abdul Rasheed, Yazeed Abed El Khaleq, Judith Abrams, Ammar Abdelaziz, Alison Abbott, Alfie Abbott, Basir Abdul, Nabeel Abdallah, Rasheed Abdul-Raheem, Mustafa Abbas, Niyaz Abdulshukkoor, Kula Abdusamad, Rebecca Abrams, A Abousamra, K Abouelela, Lynn Abel, Bushra Abdelqader, Miriam Abraham, Hani Abo-Leyah(University of Dundee), Joshua Abbas, A Abdul(Wrightington, Wigan and Leigh NHS Foundation Trust), Ashraf Omar Abdelaziz(Ain Shams University), Adebanke Aboaba, Fatima Abbas, Katrina Abernethy, Mohamed A. O. Abdelfattah, Movin Abeywickrema, Abraheem Abraheem, A Aboagye-Odei, Mona Abouzaid, Abdulfatahi Abdulmumeen, Heba Aboelela, C Abhinaya, Hyacinth-John Abu(University of Dundee), Rezan A. Kadir(The Royal Free Hospital), Abdullah Abdullah(University of Malakand), Ali Abbas(University of Dundee), Affyarsyah Abidin, Hakam Abbass, Siddiqui Abdul(Wrightington, Wigan and Leigh NHS Foundation Trust), Tizzy Abraham, Abdulakeem Ajibode
Cited by 329
Related Papers
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|The Lancet|2021|564
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
|The Lancet|2021|523
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|The Lancet|2022|384